NCT05614583

Multidisciplinary Digital Therapeutics of Patellofemoral Pain Syndrome Versus Usual Care

Multidisciplinary Digital Therapeutics of Patellofemoral Pain Syndrome Versus Usual Care, a Randomized Controlled Pilot Study

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 35 (actual)
• Sponsor: EverEx Inc. · Industry
• Sex: All
• Age: 19 Years – 50 Years
• Healthy volunteers: Not accepted

Summary

This randomized controlled pilot study will be evaluating an app, MORT-PFPS app (ETH-01K), owned by EverEx, Inc., to examine safety and effectiveness in individuals with patellofemoral pain syndrome.

Detailed description

This randomized controlled pilot study will enroll 40 participants, where half will be randomly assigned to the app, MORT-PFPS (n = 20), and half will be assigned to treatment as usual (TAU) (n = 20), to examine safety and effectiveness in individuals with patellofemoral pain syndrome. All subjects will be followed up in the study for a total of 12 weeks, 8-week courses of treatment with additional 4-week observation. The app provides multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.

Conditions

• Patellofemoral Pain Syndrome

Interventions

Type	Name	Description
DEVICE	MORT-PFPS app	The MORT-PFPS, developed by EverEx, Inc., is designed to provide multidisciplinary rehabilitation treatment, a combination of graded exercise therapy and cognitive behavioural therapy for patients with patellofemoral pain syndrome.
OTHER	treatment as usual (TAU)	In the control group, psychoeducation is delivered and self-exercise is recommended.

Timeline

• Start date: 2022-11-16
• Primary completion: 2023-10-19
• Completion: 2023-10-19
• First posted: 2022-11-14
• Last updated: 2024-07-31

Locations

2 sites across 1 country: South Korea